Although patients who developed severe pneumonia in COVID-19 had significantly higher levels of IL-10 than those with milder illness, patients who proceeded to develop DHF, had several fold higher levels during early illness (Fig. 3a). This evidence concerns the gene IL10 and susceptibility to pneumonia measurement.